Relapse

Quantification of Peripheral Blood iNKTs After Allogeneic Stem Cell Transplantation

Study of the Impact on the Evolution of the Disease in the Medium Term of the Implementation of a System of Extended Follow-up by Telephone Interview of Patients With an Eating Disorder Organized by the Nurses of the Eating Disorder Referral Center

Adapted RPM-08 for Substance Use Disorder in Pakistan

Study of Autologous CAR-T Cells Targeting B7-H3 in TNBC iC9-CAR.B7-H3 T Cells

A Phase 1 Clinical Trial of AUR106 in Patients With Relapsed Advanced Malignancies

Autologous CAR-T Cells Targeting B7-H3 in PDAC

EUS-guided CTCs + Multi-omics: Predicting Pancreatic Cancer Recurrence and Metastases

Epcoritamab in Combination With Loncastuximab Tesirine in Relapsed/Refractory Large B-cell Lymphoma

Autologous CAR-T Cells Targeting CSPG4 in Relapsed/Refractory HNSCC

CD19 CAR T Cells in Patients With Relapsed or Refractory CD19 Positive B-cell Lymphoma

Motivational Interviews Post Hospitalisation on Maintaining AbstiNence for 1 Year après le Sevrage en Alcool

Dose-Escalation Study of Oral Administration of LP-108 as Monotherapy and in Combination With Azacitidine in Patients With Relapsed or Refractory MDS, CMML, or AML

The Safety and Efficacy of Daratumumab in Patients With Refractory Aplastic Anemia

Autologous/Allogeneic TGFbeta-resistant LMP-specific CTL, Lymphoma (TGF-beta)

Isa-Pom-Dex in Elderly/Frail Subjects With RRMM

ATLCAR.CD30.CCR4 for CD30+ HL ATLCAR.CD30.CCR4 Cells

Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM

IA Carboplatin + Radiotherapy in Relapsing GBM

Intraarterial Carboplatin + Caelyx vs Intraarterial Carboplatin + Etoposide Phosphate for Progressing Glioblastoma

Effectiveness and Safety of Blinatumomab and Donor Lymphocyte Infusion in Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation for High-risk Ph Negative B Cell Acute Lymphoblastic Leukemia